Cargando…

Correction to: SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Liu, Xiao-han, Li, Cong, Wu, Xiao-xing, Chen, Yan-lin, Li, Wen-wen, Li, Xian, Gong, Fan, Tang, Qin, Jiang, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301439/ https://www.ncbi.nlm.nih.gov/pubmed/32552756 http://dx.doi.org/10.1186/s13046-020-01596-w

Ejemplares similares

SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
por: Zhang, Jing, et al.
Publicado: (2020)

Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose
por: Fei, Jing, et al.
Publicado: (2021)

Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
por: Zi, Dan, et al.
Publicado: (2022)

Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
por: Zi, Dan, et al.
Publicado: (2023)

Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease
por: Strohl, Anna, et al.
Publicado: (2016)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2020)

Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway
por: Zhao, Kai-Hong, et al.
Publicado: (2017)

Author Correction: Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer
por: Hao, Xiang-lin, et al.
Publicado: (2019)

Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer
por: Li, Yi, et al.
Publicado: (2023)

A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway
por: Liang, Wei, et al.
Publicado: (2021)

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
por: Azzalini, Eros, et al.
Publicado: (2022)

Correction: Small extracellular vesicles derived from embryonic stem cells restore ovarian function of premature ovarian failure through PI3K/AKT signaling pathway
por: Liu, Mengyu, et al.
Publicado: (2023)

Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma
por: Serna-Gallegos, Tasha, et al.
Publicado: (2016)

Low-Grade Ovarian Serous Adenocarcinoma with Lymph Node Metastasis in Neck
por: Chen, Shih-Lung, et al.
Publicado: (2021)

Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT
por: Li, Xinxing, et al.
Publicado: (2019)

CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
por: Zhang, Li Q., et al.
Publicado: (2019)

Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway
por: Zhang, Mao, et al.
Publicado: (2019)

Correction: H(2)O(2) treatment or serum deprivation induces autophagy and apoptosis in naked mole-rat skin fibroblasts by inhibiting the PI3K/Akt signaling pathway
por: Zhao, Shanmin, et al.
Publicado: (2017)

Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo
por: Yang, Hong, et al.
Publicado: (2018)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Skin Metastasis of Low-Grade Ovarian Serous Carcinoma: A Case Report
por: Ching, Lauren M, et al.
Publicado: (2023)

Correction: Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq
por: Shih, Andrew J., et al.
Publicado: (2018)

Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway
por: Zhang, Fei, et al.
Publicado: (2021)

Correction: Melatonin suppresses chronic restraint stress-mediated metastasis of epithelial ovarian cancer via NE/AKT/β-catenin/SLUG axis
por: Bu, Shixia, et al.
Publicado: (2020)

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
por: Cui, Ran, et al.
Publicado: (2019)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

MicroRNA-101 inhibits growth and metastasis of human ovarian cancer cells by targeting PI3K/AKT
por: Wei, Min, et al.
Publicado: (2019)

Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2021)

Author Correction: Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
por: Liu, Jie, et al.
Publicado: (2020)

Author Correction: Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
por: Liu, Jie, et al.
Publicado: (2023)

Correction: MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
por: Zhao, Guangyi, et al.
Publicado: (2013)

IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer
por: Dongol, Samina, et al.
Publicado: (2020)

High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer
por: Song, Li, et al.
Publicado: (2019)

Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma
por: Zhu, Qian, et al.
Publicado: (2023)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis
por: Gagné, Andréanne, et al.
Publicado: (2018)

Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium
por: Goranova, T, et al.
Publicado: (2019)

THBS1-Mediated Degradation of Collagen via the PI3K/AKT Pathway Facilitates the Metastasis and Poor Prognosis of OSCC
por: Wen, Zhihao, et al.
Publicado: (2023)

MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis
por: Dian, Mei-Juan, et al.
Publicado: (2021)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fkoefofectujv7i7luaoqvegop